Life-Sciences-Europe.com
The European Life Sciences Web Portal

This is a free web portal for the life sciences in Europe and Israel... » read more

Servier to Acquire Symphogen for Undisclosed Sum (2020-04-03)
> Servier strengthens its R&D pipeline by acquiring Symphogen’s antibody pipeline and next-generation antibody technologies. > Symphogen becomes the antibody center of excellence within Servier. > Securing Servier’s ambition to become a recognized player in o...
ERS Genomics & Axxam: CRISPR/Cas9 License Agreement (2020-04-02)
ERS Genomics Limited (“ERS Genomics”), which was formed to provide broad access to the foundational CRISPR-Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Axxam S.p.A. (“Axxam”), a leading discovery biology company, today announced the signin...
Evotec Licenses iPSC Technologies from PanCella (2020-04-02)
> EVOTEC LICENSES PANCELLA'S STATE-OF-THE-ART IPSC TECHNOLOGIES IACT STEALTH CELL(TM) AND FAILSAFE(TM) FOR USE IN CELL THERAPY > ACCESS TO PANCELLA'S TECHNOLOGY HAS THE POTENTIAL TO ENABLE SAFE AND OFF-THE-SHELF CELL THERAPY PRODUCTS AND LIFTS EVOTEC'S IPSC-BASE...
iTeos Therapeutics Closes $125m Series B2 Financing (2020-04-01)
- Proceeds support advancing clinical development of next-generation cancer immunotherapies targeting A2A adenosine receptor and anti-TIGIT immune checkpoint - - Oversubscribed round co-led by new investors RA Capital Management and Boxer Capital - - New inv...
Danaher Completes Acquisition GE’s Biopharma Business (2020-03-31)
Danaher Corporation (NYSE: DHR) ("Danaher") announced today the completion of its acquisition of the Biopharma business from General Electric Company's (NYSE: GE) Life Sciences division. As part of Danaher, the business will be called Cytiva and will be a standalon...
AM-Pharma Increases Funding to €163m for Phase 3 of recAP (2020-03-31)
> €23m (US$25.5m) equity provided mainly by US-based Cowen Healthcare Investments > €24m (US$26.5m) finance facility provided by the European Investment Bank (EIB) > Increased funding allows for finalization of all Marketing Authorization Application preparat...
Gilde Healthcare Raises €416m Venture & Growth Capital Fund (2020-03-31)
Gilde Healthcare today announces the first and final close of Gilde Healthcare V, a €416 million ($450 million) venture and growth capital fund. The new fund, which was oversubscribed, targets growth opportunities in a broad range of healthcare sectors including di...
Ildong Pharmaceuticals to Use Evotec’s INDiGO Platform (2020-03-31)
> EVOTEC LEVERAGES INDIGO PLATFORM TO ACCELERATE DEVELOPMENT OF VARIOUS ILDONG PROGRAMMES INTO THE CLINIC > FIRST REGULATORY FILING ENVISAGED FOR Q1 2021 > INDIGO IS A KEY VALUE-DRIVING COMPONENT OF EVOTEC'S EVT EXECUTE BUSINESS SEGMENT AIMED AT REDUCING TIME...
Owlstone Medical Appoints Neil Tween as CFO (2020-03-30)
Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine today announces the appointment of Neil Tween as its new Chief Financial Officer. Owlstone Medical is in the unique position of establishing ...
ImaginAb & AZ: Licensing Deal for CD8 ImmunoPET Technology (2020-03-30)
ImaginAb Inc., a leading clinical stage immuno-oncology imaging company, today announced it has signed a multi-year non-exclusive license agreement with AstraZeneca. Under the terms of the agreement, ImaginAb’s CD8 ImmunoPET technology will be used in AstraZenec...

» Show all News!"

Life-Sciences-Europe.com is your doorway to the European life sciences!

[LSE] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!

Start here with the latest News!

Picture [iito] – Putting Information into Context 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]